Ignite Creation Date:
2024-05-06 @ 10:03 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03147313
Status:
UNKNOWN
Last Update Posted:
2021-09-05
First Post:
2017-04-21
Brief Title:
Extracorporal Shock Wave Treatment to Improve Nerve Regeneration
Sponsor:
Ludwig Boltzmann Gesellschaft
Organization:
Ludwig Boltzmann Gesellschaft
Study Overview
Official Title:
Extracorporal Shock Wave Treatment After Microsurgical Coaptation to Improve Nerve Regeneration
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves Participants will be randomized into two treatment groups with different settings and a sham group The participants will thereafter followed-up in a prospective double-blind study design
Detailed Description:
Extracorporeal shock wave treatment is CE certified in Austria Europe and licensed for indications like achillodynia epicondylitis or tendinitis calcanea The Orthogold 100 device by MTS Medical UG will be used for this study
Defocused low-energy extracorporeal shock wave therapy ESWT has gained acceptance as a therapeutic tool in different medical settings It has been shown that shock waves stimulate of the metabolic activity of different cell type including osteoblasts tenocytes endothelial cells and chondrocytes Furthermore it has proved effective in clinical applications relating to bone and wound healing and myocardial ischaemia Until now no studies have been performed regarding the effects of ESWT on regeneration of peripheral nerve injuries in humans
Defocused low-energy extracorporeal shock wave therapy ESWT has gained acceptance as a therapeutic tool in different medical settings It has been shown that shock waves stimulate of the metabolic activity of different cell type including osteoblasts tenocytes endothelial cells and chondrocytes Furthermore it has proved effective in clinical applications relating to bone and wound healing and myocardial ischaemia Until now no studies have been performed regarding the effects of ESWT on regeneration of peripheral nerve injuries in humans
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None